Cannabis Strategic Ventures
$0.00-$0.00 (-16.67%)
Cannabis Strategic Ventures’s quoted price sits in the lower half of its reported 52-week range, 95.55% below the high.
OTC · DZCA · USD
Stock price, earnings
Quote as of Oct 28, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
DrazCanna, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow DrazCanna, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Operating as Global Personalized Academics, DrazCanna, Inc. functions as an educational enterprise. It delivers both virtual and in-person learning resources to students and teachers across the globe. The company's diverse offerings include digital curricula designed for K-12 students, covering essential subjects, electives, Advanced Placement (AP) courses, world languages, and credit recovery programs. Additionally, DrazCanna provides professional development for educators, available through both online platforms and traditional classroom sessions, along with access to learning management software. Its services extend to comprehensive online school solutions, which bundle online courses, learning management systems, and instructor support, typically charged per student on a semester basis. International dual-diploma courses are also part of its portfolio. The company currently serves approximately 150 school districts throughout the United States. DrazCanna, Inc. was established in 2010 and is headquartered in Orlando, Florida. It previously operated under the name Sibling Group Holdings, Inc., before officially changing to DrazCanna, Inc. in March 2022.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:09 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.00-$0.00 (-16.67%)
Cannabis Strategic Ventures’s quoted price sits in the lower half of its reported 52-week range, 95.55% below the high.
$0.00$0.00 (0.0%)
North American Cannabis Holdings, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Regenicin, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.99% below the high.
$0.00$0.00 (0.0%)
Aeolus Pharmaceuticals, Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.00$0.00 (0.0%)
Halo Collective Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.00$0.00 (0.0%)
VioQuest Pharmaceuticals, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
MPX International Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Sentry Petroleum Ltd: Healthcare · Drug Manufacturers - Specialty & Generic.